resveratrol has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonavida, B; Jazirehi, AR | 1 |
1 other study(ies) available for resveratrol and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; bcl-X Protein; Caspases; Cell Cycle; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; G2 Phase; Humans; Immunoblotting; Intracellular Membranes; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Membrane Potentials; Mitochondria; Models, Biological; Multiple Myeloma; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Time Factors; Transcription Factor AP-1 | 2004 |